Skip to main content
. 2015 Sep 22;2015(9):CD001191. doi: 10.1002/14651858.CD001191.pub4

2.16. Analysis.

2.16

Comparison 2 Rivastigmine oral capsules (1 to 4 mg/day or 6 to 12 mg/day in two divided doses) versus placebo, Outcome 16 at least one adverse event by 26 weeks.